Caprico Biotechnologies Competitors and Similar CompaniesClear all
Caprico Biotechnologies's competitors and similar companies include Bristol Myers Squibb, Biosonda and Novartis.
 Caprico Biotechnologies Caprico Biotechnologies (CBI) is a biotech company focused on developing and commercializing antibody reagents for flow cytometry applications. |  Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. |  Biosonda Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | |
Founding Date | Founding Date 2013 | Founding Date 1887 | Founding Date 1992 | Founding Date 1996 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Norcross, US HQ | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations Miami, US HQ Ñuñoa, CL | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more |
Employees | Employees 17 | Employees 34,100 | Employees N/A | Employees 75,883 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $48.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $13.9b (FY, 2025) | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $34.3b (FY, 2025) | Gross profit N/A | Gross profit $49.8b (FY, 2025) |
Net income | Net income N/A | Net income $7.1b (FY, 2025) | Net income N/A | Net income $14b (FY, 2025) |
Operating ⚠ | ||||
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 7 (FY, 2021) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 27 (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 15.5m | Total funding raised N/A | Total funding raised $ 6.5m |
For sources of this data, please see the company profile
View Company Profiles
Bristol Myers Squibb
HQ
Princeton, US
Employees
34,100
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View companyBiosonda
HQ
Miami, US
Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company